Skip to main content
AmigoFish

The Science of Myostatin inhibitors, GLP-1 meds and Muscle Mass

From Docs Who Lift · · 28 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

- Dr. Grant Tinsley joins the discussion as the body composition expert.

- Myostatin is a key regulator of muscle growth.

- Wendy Whippete the most jacked muscled up dog (https://www.timescolonist.com/local-news/wendy-the-whippet-famed-for-massive-muscles-has-died-4645620)

- The concern of GLP-1 receptor agonists and muscle mass loss.

- Overview of Courage trial looking at semaglutide and trevogrumab and lean mass loss (https://newsroom.regeneron.com/news-releases/news-release-details/interim-results-ongoing-phase-2-courage-trial-confirm-potential)

- Upcoming Believe trial coming out (bimagrumab and semaglutide) (https://www.adameetingnews.org/researchers-to-share-weight-loss-results-from-bimagrumab-and-semaglutide-combo/)

- Exercise remains crucial for muscle health and function.

- MRI data from SURPASS MRI provides new insights into muscle volume changes. (https://www.thelancet.com/journals/landia/article/PIIS2213-8587(25)00027-0/fulltext)

- The combination of medications may have varying effects on muscle mass.

- Caution is advised regarding the long-term effects of new drugs.

- Clinical benefits of medications often outweigh concerns about muscle loss.

- Future research will explore the synergy between exercise and medication.

Other docs who lift podcasts with Dr. Grant:

Tirzepatide muscle loss (https://podcasts.apple.com/us/podcast/tirzepatide-and-muscle-loss-with-dr-grant-tinsley/id1611961208?i=1000696844484)

Lean mass loss and GLP-1 meds (https://podcasts.apple.com/us/podcast/glp-1-agonists-and-lean-body-mass-loss-part-2-w-dr/id1611961208?i=1000610443673)

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com (https://pcm.adswizz.com) for information about our collection and use of personal data for advertising.

Back to Docs Who Lift · Report a problem